admin
Wolf, N. K., Kissiov, D. U. & Raulet, D. H. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat. Rev. Immunol. 23, 90–105 (2023).
Cózar, B. et al. Tumor-infiltrating natural killer cells. Cancer Discov. 11, 34–44 (2021).
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O. & Borrego, F. NK cell metabolism and tumor microenvironment. Front. Immunol. 10, 2278 (2019).
Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657–671 (2016).
Husain, Z., Huang, Y. N., Seth, P. & Sukhatme, V. P. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J. Immunol. 191, 1486–1495 (2013).
Harmon, C. et al. Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis. Cancer Immunol. Res. 7, 335–346 (2019).
Zheng, X. H. et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat. Immunol. 20, 1656 (2019).
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
Irizarry-Caro, R. A. et al. TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation. Proc. Natl Acad. Sci. USA 117, 30628–30638 (2020).
Xiong, J. et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol. Cell 82, 1660–1677 (2022).
Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 40, 110986 (2022).
Fan, W. et al. Global lactylome reveals lactylation-dependent mechanisms underlying T17 differentiation in experimental autoimmune uveitis. Sci. Adv. 9, eadh4655 (2023).
Wang, Z. H. et al. Altered phenotypic and metabolic characteristics of FOXP3CD3CD56 natural killer T (NKT)-like cells in human malignant pleural effusion. Oncoimmunology 12, 2160558 (2023).
Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916–921 (2000).
Soto, C. A., Lesch, M. L., Munger, J. C. & Frisch, B. J. Effects of elevated lactate in the bone marrow microenvironment during acute myeloid leukemia. Blood 140, 8620–8621 (2022).
Chen, Y. et al. Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8 T cells. Am. J. Cancer Res. 11, 5726–5742 (2021).
Cantó, C., Menzies, K. J. & Auwerx, J. NAD Metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31–53 (2015).
Stein, L. R. & Imai, S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol. Metab. 23, 420–428 (2012).
Zou, Y. J. et al. Illuminating NAD metabolism in live cells and using a genetically encoded fluorescent sensor. Dev. Cell 53, 240–252 (2020).
Rajman, L., Chwalek, K. & Sinclair, D. A. Therapeutic potential of NAD-boosting molecules: the evidence. Cell Metab. 27, 529–547 (2018).
Trammell, S. A. J. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).
Zhang, H. B. et al. NAD repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436–1443 (2016).
Li, J. H. et al. MEF2C regulates NK cell effector functions through control of lipid metabolism. Nat. Immunol. 25, 928–928 (2024).
Brown, K. D. et al. Activation of SIRT3 by the NAD precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab. 20, 1059–1068 (2014).
Cantó, C. et al. The NAD precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838–847 (2012).
Jin, J. et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 24, e56052 (2023).
Uhlen, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
Archer, S. L. Mitochondrial dynamics—mitochondrial fission and fusion in human diseases. N. Engl. J. Med. 369, 2236–2251 (2013).
Brand, C. S., Tan, V. P., Brown, J. H. & Miyamoto, S. RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes. Cell Signal. 50, 48–57 (2018).
Esposito, D. et al. ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation. Nat. Commun. 13, 703 (2022).
Li, Q. F. et al. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3. Clin. Transl. Med. 12, e1036 (2022).
Li, X. L. et al. Lactate metabolism in human health and disease. Signal Transduct. Target. Ther. 7, 305 (2022).
Apostolova, P. & Pearce, E. L. Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment. Trends Immunol. 43, 969–977 (2022).
Bergers, G. & Fendt, S. M. The metabolism of cancer cells during metastasis. Nat. Rev. Cancer 21, 162–180 (2021).
Moreno-Yruela, C. et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci. Adv. 8, eabi6696 (2022).
Fan, W. et al. A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol. 25, 165 (2024).
Myers, J. A. & Miller, J. S. Exploring the NK cell platform for cancer immunotherapy. Nat. Rev. Clin. Oncol. 18, 85–100 (2021).
Daher, M. et al. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood 137, 624–636 (2021).
Laskowski, T. J., Biederstädt, A. & Rezvani, K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat. Rev. Cancer 22, 557–575 (2022).
Vago, L. & Gojo, I. Immune escape and immunotherapy of acute myeloid leukemia. J. Clin. Invest. 130, 1552–1564 (2020).
Bhansali, R. S., Pratz, K. W. & Lai, C. Recent advances in targeted therapies in acute myeloid leukemia. J. Hematol. Oncol. 16, 29 (2023).
Liu, H. T. Emerging agents and regimens for AML. J. Hematol. Oncol. 14, 49 (2021).
Hansrivijit, P., Gale, R. P., Barrett, J. & Ciurea, S. O. Cellular therapy for acute myeloid leukemia—current status and future prospects. Blood Rev. 37, 100578 (2019).
Christopher, M. J. et al. Immune escape of relapsed AML cells after allogeneic transplantation. N. Engl. J. Med. 379, 2330–2341 (2018).
Zeiser, R. & Vago, L. Mechanisms of immune escape after allogeneic hematopoietic cell transplantation. Blood 133, 1290–1297 (2019).
Toffalori, C. et al. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat. Med. 25, 603–611 (2019).
Cooley, S., Parham, P. & Miller, J. S. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood 131, 1053–1062 (2018).
Merindol, N., Charrier, E., Duval, M. & Soudeyns, H. Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation. J. Leukoc. Biol. 90, 49–60 (2011).
Locatelli, F. et al. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplant. 18, 1095–1101 (1996).
Xu, J. & Niu, T. Natural killer cell-based immunotherapy for acute myeloid leukemia. J. Hematol. Oncol. 13, 167 (2020).
Wang, D. Y. et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post-allo-HSCT. Blood 140, 2788–2804 (2022).
Liu, Y. J. et al. Inhibition of p300 impairs Foxp3 T regulatory cell function and promotes antitumor immunity. Nat. Med. 19, 1173–1177 (2013).
Capello, M. et al. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget 7, 5598–5612 (2016).
Li, X. J. et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol. Cell 61, 705–719 (2016).
Wu, Z. Q. et al. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8 T cells. J. Clin. Invest. 132, e155224 (2022).
Aydin, E., Johansson, J., Nazir, F. H., Hellstrand, K. & Martner, A. Role of NOX2-derived reactive oxygen species in NK cell-mediated control of murine melanoma metastasis. Cancer Immunol. Res. 5, 804–811 (2017).
